Research Study

Shortened Spadin Analogs Display Better TREK-1 Inhibition, In Vivo Stability and Antidepressant Activity.

📅 2020 🔗 DOI: 10.3389/fphar.2017.00643
Citation
Djillani A., Pietri M., Moreno S., Heurteaux C., Mazella J. et al. (2020). Shortened Spadin Analogs Display Better TREK-1 Inhibition, In Vivo Stability and Antidepressant Activity.. Front Pharmacol. DOI: 10.3389/fphar.2017.00643
View Full Study →

Abstract

Abstract not available. See citation for source.

Disclaimer: This research summary is for educational purposes only. Always consult with a healthcare professional before making decisions based on scientific research.